We are live on ! Find out more

23 hedge funds and large institutions have $2.66M invested in Imunon in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more call options, than puts

Call options by funds: $219K | Put options by funds: $101K

0.65% more ownership

Funds ownership: 0.05%0.7% (+0.65%)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

36% less capital invested

Capital invested by funds: $4.14M → $2.66M (-$1.49M)

38% less funds holding

Funds holding: 3723 (-14)

81% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 16

Holders
23
Holders Change
-14
Holders Change %
-37.84%
% of All Funds
0.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
6
Closed
16
Calls
$219K
Puts
$101K
Net Calls
+$118K
Net Calls Change
+$46K

IMNN Hedge Fund Activity: Q1 2022 in Review

23 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q1 2022, worth a combined $2.66M — down 36% from $4.14M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of IMNN and 3 opened new positions — a net loss of 13 holders — while 6 trimmed existing stakes and 6 added.

The largest buyer was Citadel Advisors, adding an estimated $184K. The largest seller was Vanguard Group, cutting an estimated $145K.

  • 23 institutional investors held Imunon (IMNN) as of Q1 2022, down from 37 in Q4 2021.
  • Funds reported $2.66M of Imunon stock for Q1 2022, down 36% quarter-over-quarter.
  • 3 funds opened new Imunon positions in Q1 2022 and 16 closed out, a net change of -13 holders.
  • The largest Imunon buyer in Q1 2022 was Citadel Advisors, an estimated $184K added.
  • The largest Imunon seller in Q1 2022 was Vanguard Group, an estimated $145K sold.

Based on aggregated 13F filings for Q1 2022.